anyone else out there a holder of A? Is this rather large dip an opportunity, or not? Now at $32.44. Dissapointing 3rd qtr, lowered outlook. Japan saw orders fall 24 percent year-over-year. Doesn't sound good. Value Line had a decent review of A, calling for a solid 2nd half in 07. Thjere was a flocking to the stock in spring, with strong growth in orders in first half. VL did warn on high beta and low earn predictability.Anyone else have an opinion? I was looking at A long.from the Street today:Agilent Technologies (A) tumbled 11% after the maker of test and measurement equipment posted disappointing third-quarter results and warned that fourth-quarter results would be lower than expected. The company posted adjusted third-quarter earnings of $194 million, or 48 cents a share, on revenue of $1.37 billion. Analysts expected earnings of 49 cents a share on revenue of $1.39 billion.Looking ahead, Agilent now sees fourth-quarter earnings of 50 cents to 54 cents a share on revenue of $1.39 billion to $1.43 billion. Analysts project earnings of 58 cents a share on revenue of $1.47 billion. Shares were trading down $4 to $32.33.From AP:Agilent Shares Tumble on 3Q ResultsAPPosted: 2007-08-15 14:20:33NEW YORK (AP) - Shares of Agilent Technologies Inc. fell sharply Wednesday after the test-and-measurement company posted disappointing fiscal third-quarter results and lowered its fourth-quarter guidance. The company's results, posted Tuesday after the bell, missed Wall Street's expectations amid weakness in Asian markets. The company also lowered its revenue outlook to between $1.39 billion and $1.43 billion, below the $1.47 billion expected by analysts polled by Thomson Financial. Shares of the Santa Clara, Calif., company fell $4.13, or 11 percent, to $32.20 in afternoon trading. In the past 52 weeks, the stock has traded between $28.55 and $40.42. Agilent had reported third-quarter earnings of 45 cents per share, down from 54 cents per share last year. Revenue rose to $1.37 billion from $1.24 billion. The company's adjusted earnings fell a penny short of Wall Street expectations. Analysts said the quarter's weakness was due mainly to sales and order shortfalls at Agilent's electronic measurement business. Its bio-analytical unit, meanwhile, saw solid results. Agilent's products are used by the communications, electronics, life sciences and chemical analysis industries. The company's electronic measurement unit is faced with weakness in Asia, which accounts for 43 percent of its sales and where the company "has the largest exposure to the relatively more volatile semiconductor and consumer electronic manufacturing markets," wrote Banc of America Securities analyst Mark F. FitzGerald in a note to clients. Japan, he said, saw orders fall 24 percent year-over-year. FitzGerald kept a "Neutral" rating on Agilent and said its bio-analytical unit is benefiting from of new product traction and strong demand in both life sciences and chemical analysis. Goldman Sachs analyst Deane M. Dray said the 24 percent drop in electronic measurement orders in Japan "is likely to keep shorter-term Agilent investors on the sidelines at this time." The analyst kept a "Neutral" rating on the stock but continues to be positive on Agilent's long-term earnings potential.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Ma